Business Description
CVS Health Corp
NAICS : 621399
SIC : 8099
ISIN : US1266501006
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | 0.31 | |||||
Debt-to-Equity | 1.04 | |||||
Debt-to-EBITDA | 4.36 | |||||
Interest Coverage | 5.49 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.21 | |||||
Beneish M-Score | -2.25 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.7 | |||||
3-Year EBITDA Growth Rate | 2.7 | |||||
3-Year EPS without NRI Growth Rate | 3.5 | |||||
3-Year FCF Growth Rate | -7.6 | |||||
3-Year Book Growth Rate | 3.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | 3.7 | |||||
Future 3-5Y Total Revenue Growth Rate | 3.9 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.81 | |||||
9-Day RSI | 31.84 | |||||
14-Day RSI | 33.28 | |||||
6-1 Month Momentum % | 13.66 | |||||
12-1 Month Momentum % | 7.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.86 | |||||
Quick Ratio | 0.63 | |||||
Cash Ratio | 0.14 | |||||
Days Inventory | 21.81 | |||||
Days Sales Outstanding | 14.3 | |||||
Days Payable | 16.97 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.64 | |||||
Dividend Payout Ratio | 0.32 | |||||
3-Year Dividend Growth Rate | 6.6 | |||||
Forward Dividend Yield % | 3.83 | |||||
5-Year Yield-on-Cost % | 4.34 | |||||
3-Year Average Share Buyback Ratio | 0.6 | |||||
Shareholder Yield % | -1.52 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 15.21 | |||||
Operating Margin % | 4.08 | |||||
Net Margin % | 2.33 | |||||
FCF Margin % | 2.91 | |||||
ROE % | 11.39 | |||||
ROA % | 3.42 | |||||
ROIC % | 5.92 | |||||
ROC (Joel Greenblatt) % | 45.2 | |||||
ROCE % | 8.29 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 10.78 | |||||
Forward PE Ratio | 8.43 | |||||
PE Ratio without NRI | 9.29 | |||||
Shiller PE Ratio | 12.89 | |||||
Price-to-Owner-Earnings | 8.92 | |||||
PEG Ratio | 1.03 | |||||
PS Ratio | 0.25 | |||||
PB Ratio | 1.17 | |||||
Price-to-Free-Cash-Flow | 8.67 | |||||
Price-to-Operating-Cash-Flow | 6.72 | |||||
EV-to-EBIT | 11.27 | |||||
EV-to-Forward-EBIT | 10.21 | |||||
EV-to-EBITDA | 8.56 | |||||
EV-to-Forward-EBITDA | 8.05 | |||||
EV-to-Revenue | 0.44 | |||||
EV-to-Forward-Revenue | 0.42 | |||||
EV-to-FCF | 14.99 | |||||
Price-to-Projected-FCF | 0.51 | |||||
Price-to-Median-PS-Value | 0.6 | |||||
Earnings Yield (Greenblatt) % | 8.87 | |||||
FCF Yield % | 11.84 | |||||
Forward Rate of Return (Yacktman) % | 17.13 |